Sudip Samadder

37, S. P. Mukherjee Road, 700 026
Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Retraction Note: IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.

Retraction Note: IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.

Journal: Biochemical genetics

Published: July 24, 2026

Retraction notice to "Differential association of Hedgehog pathway in development of cervical carcinoma and its chemo-tolerance" [Pathol. - Res. Pract. 248 (2023) 154696].

Retraction notice to "Differential association of Hedgehog pathway in development of cervical carcinoma and its chemo-tolerance" [Pathol. - Res. Pract. 248 (2023) 154696].

Journal: Pathology, research and practice

Published: April 26, 2026

Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Journal: Journal of cancer research and clinical oncology

Published: January 03, 2026

Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.

Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.

Journal: Pathology, research and practice

Published: May 12, 2023

Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma.

Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma.

Journal: Cellular signalling

Published: October 08, 2022

PTPRJ is downregulated in cervical squamous cell carcinoma.

PTPRJ is downregulated in cervical squamous cell carcinoma.

Journal: Journal of genetics

Published: July 06, 2022

High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Journal: Journal of cancer research and clinical oncology

Published: November 10, 2020

Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma.

Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma.

Journal: Mutagenesis

Published: May 11, 2020

Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: Chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway.

Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: Chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway.

Journal: Genomics

Published: December 23, 2019

Deregulation of H19 is associated with cervical carcinoma.

Deregulation of H19 is associated with cervical carcinoma.

Journal: Genomics

Published: November 23, 2018

IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.

IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.

Journal: Biochemical genetics

Published: November 10, 2018

Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.

Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.

Journal: The Biochemical journal

Published: August 22, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026